3 terminated. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
| Phase 3 | 1 | Terminated 1 |
Follow Livedoid Vasculopathy: new trials by email Literature Review of Livedoid Vasculopathy trials Research Report on Livedoid Vasculopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Effect of Oral Temanogrel on Digital Blood Flow in Adult Participants With Raynaud's Phenomenon Secondary to Systemic Sclerosis Temanogrel, Placebo - Raynaud's Phenomenon Secondary to Systemic Sclerosis | Phase 2 | Terminated | Pfizer | 13 | 2021-11-03 | 2023-12-22 |
| Exparel as a Nerve Block for Severe Hand Pain liposomal bupivacaine - CREST Syndrome, Peripheral Vascular Disease | Phase 2 / Phase 3 | Terminated | Jose Soberon, MD | 13 | 2014-11-01 | 2024-05-21 |
| Efficacy of ORM-12741 for Prevention of Raynaud's Phenomenon ORM-12471 30mg, ORM-12471, placebo - Raynaud's Phenomenon | Phase 2 | Terminated | Orion Corporation, Orion Pharma | 15 | 2011-03-01 | 2014-06-27 |
Raynaud Disease (3) · Scleroderma, Systemic (2) · CREST Syndrome (1) · Peripheral Vascular Diseases (1) · Scleroderma, Diffuse (1)
Cardiovascular Diseases (3) · Connective Tissue Diseases (3) · Embolism and Thrombosis (3) · Skin Diseases (3) · Skin Diseases, Vascular (3) · Skin and Connective Tissue Diseases (3) · Thrombosis (3) · Vascular Diseases (3) · Peripheral Vascular Diseases (2) · Calcinosis (1) · Calcium Metabolism Disorders (1) · Deglutition Disorders (1) · Digestive System Diseases (1) · Esophageal Diseases (1)
APD791 (1)
Jose Soberon, MD (1) · Orion Corporation, Orion Pharma (1) · Pfizer (1)
United Kingdom (2) · United States (2)
Ariane L Herrick, MB,ChB, MD (1) · Jose Soberon, MD (1)